Performance for Resection for Primary Lung Cancer Compared to STS and National Outcomes*
* These NIS data are the most recent data available at this time. There are more resection for primary lung cancer patients in a single year of NIS data than in the GTSD, so a decision was made to use 3 years of STS GTSD data.
Resection for Primary Lung Cancer Composite Measure Rating (July 2021 - June 2024)
| Overall Composite Score | 
             99.4% 
               (99.2 - 99.6)  
             | 
          
                99.4% (99.2, 99.6)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            Better Than Expected
                           
           | 
        
| Absence of Operative Mortality | 
             99.4% 
               (99.1 - 99.7)  
             | 
          
                99.4% (99.1, 99.7)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            As Expected
                           
           | 
        
| Absence of Major Morbidity | 
             97.2% 
               (96.1 - 98.2)  
             | 
          
                97.2% (96.1, 98.2)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            Better Than Expected
                           
           | 
        
Esophagectomy Composite Measure Rating (July 2021 - June 2024)
| Overall Composite Score | 
             97.2% 
               (95.7 - 98.4)  
             | 
          
                97.2% (95.7, 98.4)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            Better Than Expected
                           
           | 
        
| Absence of Operative Mortality | 
             97.9% 
               (95.7 - 99.3)  
             | 
          
                97.9% (95.7, 99.3)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            As Expected
                           
           | 
        
| Absence of Major Morbidity | 
             89.7% 
               (84.3 - 94.0)  
             | 
          
                89.7% (84.3, 94)  
   Participant Score 
    Participant Credible Interval 
     STS Range  
    STS Average Score 
   | 
          
            
             
                            Better Than Expected
                           
           | 
        
* Resection for Primary Lung Cancer Overall Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Percentage of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery or after discharge but within 30 days of the procedure.
 - Absence of Major Morbidity: Percentage of patients [risk-adjusted] who did not experience any major complication. These are: 1) pneumonia; 2) acute respiratory distress syndrome; 3) bronchopleural fistula; 4) pulmonary embolus; 5) initial ventilator support > 48 hours; 6) reintubation/respiratory failure; 7) tracheostomy; 8) myocardial infarction; 9) unexpected return to the operating room.
 
** Esophagectomy For Esophageal Cancer Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Percentage of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery or after discharge but within 30 days of the procedure.
 - Absence of Major Morbidity: Percentage of patients [risk-adjusted] who did not experience any major complication. These are: 1) unexpected return to the operating room; 2) anastomotic leak requiring medical treatment only; 3) reintubation/respiratory failure; 4) initial ventilator support >48 hours; 5) pneumonia; 6) new renal failure per RIFLE criteria; 7) recurrent laryngeal nerve paresis.
 
